ImmunityBio converts from Immunomedics | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
ImmunityBio converts from Immunomedics

An SI Board Since February 2023

Posts	SubjectMarks	Bans	Symbol
1531	51	0	IBRX

Emcee: TinfoilHat	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
410	Ask yourself, If I did not own any IBRX now, what would I do? IF an experienced	bobbseytwins2001	5	4/25/2024
409	Now THIS is an addressable market.	ghettogoulash	-	4/25/2024
408	We’ve had nothing but good news this week. I remain perplexed by the lackluste	Olecranon	-	4/25/2024
407	I would think the next step would be an interim analysis of QUILT 2.023-- or may	ghettogoulash	-	4/25/2024
406	Key highlights: Median overall survival almost double that of standard of care c	End2War	7	4/25/2024
405	well, we have this for friday.... ImmunityBio Announces Positive Overall Surviv	JJINV	5	4/25/2024
404	Well - 40% short - guess nobody wants to buy…. Why? More sellers than buyers	JJINV	-	4/24/2024
403	Oops, I see Jargon already posted that video.	ghettogoulash	-	4/24/2024
402	What HE said! Soon-Shiong today sidestepped, yet clarified, the question on addr	ghettogoulash	-	4/24/2024
401	As ghetto said, I think PSS will clarify and also elaborate on future testing. M	zagnut1	1	4/23/2024
400	The company's PR is misleading regarding patient population. The conference	ghettogoulash	-	4/23/2024
399	Yeah, says Captain B has said “Wall Street is stupid“ I do not understand howev	JJINV	-	4/23/2024
398	With multiple platforms and no money problems I think Friday’s call could be an	zagnut1	1	4/23/2024
397	You may be right based on the inclusion of papillary. Before we were looking at	ghettogoulash	-	4/23/2024
396	finance.yahoo.com Interesting brief video interview with Soon-Shiong	jargonweary	4	4/23/2024
395	We don't agree with the concept that $3.7 billion is "pretty healthy fo	bobbseytwins2001	1	4/23/2024
394	Nice breakdown. Also, with enough volume and volatility, trading algorithms can	ghettogoulash	-	4/23/2024
393	"Cash, cash equivalents, restricted cash and short-term investments totaled	ghettogoulash	1	4/23/2024
392	ghetto, what does ABEO’s cash runway look like?	Olecranon	-	4/23/2024
391	Coincidentally, there's an IBRX/IMMU replay today in ABEO, developer of cell	ghettogoulash	-	4/23/2024
390	The only thing I can come up with is the shorts are selling small blocks and a l	zagnut1	-	4/23/2024
389	Confused also. Unless they believe there will be more dilution versus a buyout.	Davidoff	-	4/23/2024
388	short money is significant ...they are demonstrating that hedge funds control th	urslor	-	4/23/2024
387	Wow!!! I am confused, stock is going down and it just got FDA approval. We know	zagnut1	1	4/23/2024
386	TFH, 3/12/23 - “ 7. Never count out Patrick Soon-Shiong”	dorightbythem	-	4/23/2024

Go to reply# or date (mm/dd/yy):